Aimco Pesticides Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
February 11, 2023 at 07:06 am EST
Share
Aimco Pesticides Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 307.93 million compared to INR 1,008.11 million a year ago. Revenue was INR 310.15 million compared to INR 1,005.79 million a year ago. Net loss was INR 18.21 million compared to net income of INR 42.88 million a year ago. Basic loss per share from continuing operations was INR 1.9 compared to basic earnings per share from continuing operations of INR 4.47 a year ago. Diluted loss per share from continuing operations was INR 1.9 compared to diluted earnings per share from continuing operations of INR 4.47 a year ago.
For the nine months, sales was INR 1,646.85 million compared to INR 2,351.16 million a year ago. Revenue was INR 1,656.56 million compared to INR 2,357.22 million a year ago. Net income was INR 25.66 million compared to INR 80.34 million a year ago. Basic earnings per share from continuing operations was INR 2.68 compared to INR 8.38 a year ago. Diluted earnings per share from continuing operations was INR 2.68 compared to INR 8.38 a year ago.
Aimco Pesticides Limited is an India-based integrated agrochemical company. The Company is engaged in the manufacturing, marketing, and export of a diverse range of agrochemical. Its geographical segments include India and outside India. The Company produces11 key technical-grade agrochemicals within the categories of insecticides, fungicides, and herbicides. The Company produces more than 90 agrochemical formulations. Its formulations include insecticides, fungicides, herbicides, combinations, and rodenticides and fumigants. Its branded formulation portfolio consists of Aimco ASTRA, AIMFIRE, AIMCOSTAR FS, Aimco TEJA, Aimco ALTROZ, Aimco WEED NASHAK, AIMCO BARRIER, Aimco JUMPER, AIMPYRAD, AIMCO MIX, Aimco Ace, and BYKILL. The Company has a comprehensive portfolio of 11 molecules, spanning diverse categories. Its products include triclopyr, bifenthrin and chlorpyrifos (ethyl and methyl). It is engaged in both bulk business-to-business and branded business-to-consumer formulations.